INTERVIEWS

Brook West, Chief Commercial Officer at Carrum Health discusses why telehealth is not enough to save providers, health plans, and employers from a backlog of 1 million MSK surgeries delayed due to COVID-19, and how to effectively implement surgical appropriateness through value-based Centers of Excellence as part of the solution – delivering quality, less expensive care. 

David Hunt, Founder and President at Cosán discusses the company’s mission in supporting successful aging in place for older adults through preventative care management services and technology-enabled services. Cosan’s chronic care management and behavioral health integration platforms, including voiceBOTs able to recognize voice anomalies signaling signs of depression and bed sensors that monitor heart rate, allow care teams to keep patients well, and in the home, while avoiding negative events that lead to hospitalization. Cosán’s chronic care management suite includes these remote technologies as well as a dedicated team of hybrid care coordinators that simplify the aging process. 

Dr. Nadeem Dhanani, MD, MPH, Medical Director of Urology at Modernizing Medicine ® discusses their platform, telehealth, and how it can be used to improve certain practice aspects. He talks about all-in-one systems and how they can streamline workflow and efficacy, improve patient engagement, especially among younger patients, and use the power of data to identify appropriate people for clinical studies, population health, etc. 

Dr. Jonathan Chen, MD, Chief of Cardiothoracic Surgery in the Cardiac Center at Children’s Hospital of Philadelphia (CHOP) discusses congenital heart disease (CHD) and the advances in prenatal diagnosis and imaging that have allowed for early treatment for babies with birth defects like CHD. He covers several options that are improving treatment for children with heart disease and how, now, innovations in prosthetic valve repair and replacement can also provide less invasive treatment options. 

Dr. Michael Blaha, MD, MPH, Director of Clinical Research for the Prevention of Cardiovascular Disease at Johns Hopkins discusses detecting heart disease, current guidelines, adhering to treatment, and switching statins when a patient is no longer able to adhere to current therapy. LIVALO, a statin commonly used for high cholesterol, offers a Doctor Discussion Guide on its website that can help patients personalize their conversation with their doctor – whether in person or via telehealth – about their statin treatment options. 

Lisa Rose, SVP & Chief Marketing Officer with LifeScan, a diabetes management company discusses how they have teamed up with former professional football player and popular sports commentator, Mike Golic, to launch “Talking Type You“, a new campaign that not only acknowledges the personal discipline required to manage diabetes but also encourages open conversation about those realities. They will also introduce a new digital one-stop shop that offers wellness programs from experts like Noom, Fitbit, Cecelia Health, and Welldoc, and can be paired with glucose data from Bluetooth ®-connected OneTouch ® meters. 

Dr. Karen Noblett, MD, Chief Medical Officer at Axonics discusses a new innovative medical device called sacral modulation for the treatment of incontinence. She is joined by patient Jill Vanderbush who shares her experience with the sacral modulation device. 

Dr. Matthew Weir, Attending Physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital discusses the large ADMIRAL trial that confirms AlloSure ® Kidney as an effective non-invasive diagnostic that can be used routinely in the surveillance setting to assess organ health. It is an improvement over the standard-of-care serum creatinine and has become an invaluable tool for nephrologists working to preserve donated kidneys, keeping patients healthy and off dialysis.

Dr. Elizabeth Profita, MD, a pediatric cardiologist at Stanford Children’s Health discusses how to weigh the risks and benefits of COVID-19 vaccination in different age groups, with a focus on the risk of myocarditis and whether myocarditis rates are expected to rise as boosters are rolled out to younger groups.

Murali Doraiswamy, MBBS, FRCP, Professor of Psychiatry and Behavioral Sciences at Duke University School of Medicine discusses recent findings from a survey released by Compass Pathways plc, a mental health care company, and Sermo, a global leader in physician insights, that showed two-thirds of doctors believe psilocybin therapy has potential therapeutic benefit, especially for patients with treatment-resistant depression.